Showing all 4 results
Cyclosporine tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, SMEDDS Liquid-Filled Soft Gelatin Capsule, packed exclusively in highly secure, moisture-resistant heavy-gauge Alu-Alu blister strips to ensure the absolute chemical and physical stability of the volatile microemulsion.
Active Ingredient Strength Primary Clinical Function Cyclosporine USP/Ph.Eur. (Modified) 25 mg / 50 mg The Micro-Titration Anchor: The definitive units utilized for extremely precise, weight-based dose adjustments during the critical early post-transplant phase, or for pediatric dosing. Cyclosporine USP/Ph.Eur. (Modified) 100 mg The Transplant Macrodose: The heavy therapeutic payload required to minimize the total pill burden for adult patients maintaining long-term solid organ graft survival. Excipients (SMEDDS Matrix) Polyoxyl 40 Hydrogenated Castor Oil / Polysorbate 80 / Propylene Glycol / Corn Oil Mono-di-triglycerides / Alpha-Tocopherol Microemulsion Vehicles & Surfactants / Co-Solvent / Lipophilic Carrier / Antioxidant (Engineered specifically to keep the massive lipophilic peptide fully dissolved inside the gelatin shell, instantly forming nanometer-sized droplets upon contact with stomach acid for maximum bioavailability) *Pack Sizes: 5×10 or 10×10 Alu-Alu Blisters (Optimized specifically for strict, lifelong immunosuppressive dispensing regimens).
Everolimus Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Antioxidant-Stabilized Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the highly oxidative, potent API.
Active Ingredient Strength Primary Clinical Function Everolimus USP/Ph.Eur. 0.25 mg / 0.5 mg / 0.75 mg Global Transplant Standard: Ultra-micro doses utilized for strict, lifelong immunosuppression following renal or hepatic allografts. Requires extreme content uniformity to maintain the narrow therapeutic blood trough levels (3 to 8 ng/mL). Everolimus USP/Ph.Eur. 5 mg / 10 mg Global Oncology Standard: Massive-dose antineoplastic payload utilized for the aggressive suppression of Renal Cell Carcinoma, Neuroendocrine Tumors (NETs), and HR+/HER2- Breast Cancer. Excipients Butylated Hydroxytoluene (BHT) / Hypromellose / Lactose Anhydrous / Crospovidone / Magnesium Stearate Antioxidant / Binder / Diluent / Superdisintegrant / Lubricant (Engineered specifically utilizing BHT (Butylated Hydroxytoluene) to prevent the rapid oxidative degradation of the Everolimus molecule, guaranteeing maximum clinical shelf-life and potency across harsh climates) *Pack Sizes: 10×10 Alu-Alu Blisters (Transplant) or 3×10 Alu-Alu Blisters (Oncology – 30 Day Supply).
Mycophenolate mofetil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant and handler-protective Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Mycophenolate Mofetil USP/Ph.Eur. 250 mg Dose-Titration / Pediatric Standard: Base therapeutic unit for precise plasma-level titration and pediatric transplant management. Mycophenolate Mofetil USP/Ph.Eur. 500 mg Global Transplant Standard: High-dose adult maintenance therapy for the aggressive prevention of solid organ rejection. Excipients Microcrystalline Cellulose / Povidone K-90 / Croscarmellose Sodium / Magnesium Stearate / Premium Opadry Film Diluent / Binder / Superdisintegrant / Heavy Film-Coating (Engineered specifically to create a dense, impenetrable barrier over the cytotoxic API core, ensuring absolute handling safety for nurses and pharmacists) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, chronic post-transplant dispensing regimens).
Sirolimus Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Nano-crystal Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute kinetic stability of the sensitive macrolide API.
Active Ingredient Strength Primary Clinical Function Sirolimus USP/Ph.Eur. 1 mg Global Standard: Base titration unit for precise blood-level adjustments in renal transplant recipients. Sirolimus USP/Ph.Eur. 2 mg Standard daily maintenance dose (following initial loading protocols). Excipients Macrogol / Microcrystalline Cellulose / Sucrose / Povidone / Magnesium Stearate Solid Dispersion Carrier / Diluent / Binder (Engineered to drastically enhance the systemic absorption of the highly insoluble API) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 100 (Optimized specifically for strict, life-long transplant adherence regimens).
